207 related articles for article (PubMed ID: 10096535)
1. Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy.
Mendez JC; Sia IG; Tau KR; Espy MJ; Smith TF; Chou S; Paya CV
Transplantation; 1999 Mar; 67(5):755-7. PubMed ID: 10096535
[TBL] [Abstract][Full Text] [Related]
2. Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene.
Leung PYM; Tran T; Testro A; Paizis K; Kwong J; Whitlam JB
Transpl Infect Dis; 2019 Dec; 21(6):e13168. PubMed ID: 31498954
[TBL] [Abstract][Full Text] [Related]
3. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report.
Green CB; O'Riordan A; Griffiths P; Haque T
J Clin Virol; 2016 Jul; 80():24-6. PubMed ID: 27131599
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
5. Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load.
Sohrabi M; Behzadian F; Hosseini SM; Lashini H
Arch Iran Med; 2016 Oct; 19(10):700-703. PubMed ID: 27743434
[TBL] [Abstract][Full Text] [Related]
6. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan.
Yang SL; Lin TW; Lin HC; Wang HY; Chang PY; Wang PN; Yang S; Lu JJ
J Microbiol Immunol Infect; 2021 Oct; 54(5):971-978. PubMed ID: 33632621
[TBL] [Abstract][Full Text] [Related]
7. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.
Marfori JE; Exner MM; Marousek GI; Chou S; Drew WL
J Clin Virol; 2007 Feb; 38(2):120-5. PubMed ID: 17157554
[TBL] [Abstract][Full Text] [Related]
8. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients.
Erice A; Gil-Roda C; Pérez JL; Balfour HH; Sannerud KJ; Hanson MN; Boivin G; Chou S
J Infect Dis; 1997 May; 175(5):1087-92. PubMed ID: 9129070
[TBL] [Abstract][Full Text] [Related]
9. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
[TBL] [Abstract][Full Text] [Related]
10. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
[TBL] [Abstract][Full Text] [Related]
11. Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovir.
Abraham B; Lastere S; Reynes J; Bibollet-Ruche F; Vidal N; Segondy M
J Clin Virol; 1999 Aug; 13(3):141-8. PubMed ID: 10443790
[TBL] [Abstract][Full Text] [Related]
12. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment.
Mousavi-Jazi M; Hökeberg I; Schloss L; Zweygberg-Wirgart B; Grillner L; Linde A; Brytting M
Transpl Infect Dis; 2001 Dec; 3(4):195-202. PubMed ID: 11844151
[TBL] [Abstract][Full Text] [Related]
14. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
[TBL] [Abstract][Full Text] [Related]
15. Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance.
Bowen EF; Johnson MA; Griffiths PD; Emery VC
J Virol Methods; 1997 Nov; 68(2):225-34. PubMed ID: 9389413
[TBL] [Abstract][Full Text] [Related]
16. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.
Chou S; Marousek G; Guentzel S; Follansbee SE; Poscher ME; Lalezari JP; Miner RC; Drew WL
J Infect Dis; 1997 Sep; 176(3):786-9. PubMed ID: 9291334
[TBL] [Abstract][Full Text] [Related]
17. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
[TBL] [Abstract][Full Text] [Related]
18. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
[TBL] [Abstract][Full Text] [Related]
20. High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations.
Baradhi KM; Aure RL; El-Amm JM
Transplant Proc; 2018; 50(1):142-144. PubMed ID: 29407298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
